机译:复发/难治急性淋巴细胞白血病患者同种异体和自体嵌合抗原受体T细胞疗法的回顾性比较
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Zhejiang Univ PETCT Ctr Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou;
Innovat Cellular Therapeut Co Ltd Shanghai Peoples R China;
Shanghai YaKe Biotechnol Ltd Shanghai Peoples R China;
Innovat Cellular Therapeut Co Ltd Shanghai Peoples R China;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
Shanghai YaKe Biotechnol Ltd Shanghai Peoples R China;
Zhejiang Univ Bone Marrow Transplantat Ctr Affiliated Hosp 1 Sch Med Hangzhou Zhejiang;
机译:复发/难治急性淋巴细胞白血病患者同种异体和自体嵌合抗原受体T细胞疗法的回顾性比较
机译:低剂量CD19靶向嵌合抗原受体T(CAR-T)细胞免疫疗法在47例难治性B细胞急性淋巴细胞白血病(B-ALL)复发患者中的安全性和有效性
机译:抗CD19嵌合抗原受体改性T细胞治疗转发/难治性B细胞急性淋巴细胞白血病的同种异体造血干细胞移植桥接:开放式务实临床试验
机译:从用于嵌合抗原受体(CAR)T细胞制造的自体白细胞去除髓样细胞可改善最终产品的一致性和产量
机译:培养的人类免疫细胞,培养的人类急性淋巴细胞白血病细胞和急性粒细胞性白血病患者呼气中的挥发性生物标志物
机译:复发/难治性急性淋巴细胞白血病患者CD19单型和CD19 / CD22双特异性嵌合抗原受体T细胞治疗的回顾性比较
机译:复发/难治急性淋巴细胞白血病患者同种异体和自体嵌合抗原受体T细胞疗法的回顾性比较